What does elevated serum lipase indicate?

Elevated serum lipase is best viewed as a marker requiring clinical context: it may reflect pancreatic injury or non-pancreatic causes such as reduced renal clearance, but it is not a measure of digestive enzyme delivery to the intestine.

Clinical interpretation of elevated lipase

• Acute pancreatitis is supported when at least two of three features are present: characteristic upper-abdominal pain, lipase/amylase >3 times the upper limit of normal, and compatible imaging.
• Lipase elevation alone is not diagnostic. In a prospective cohort of 808 people with lipase ≥3-fold elevated, 392 had acute pancreatitis and 401 had non-pancreatic hyperlipasemia.
• Thus, even marked elevation should be interpreted alongside symptoms, examination, imaging when indicated, and concurrent illness.

Renal clearance and non-pancreatic hyperlipasemia

• Lipase is renally filtered, with tubular reabsorption and degradation. Reduced filtration can therefore raise circulating lipase.
• Acute kidney injury was the most common identified cause of non-pancreatic hyperlipasemia in the prospective cohort (33.2%).
• Renal dysfunction is a plausible contributor, not a lipase-specific explanation: concentrations do not consistently track kidney function, and sepsis and other illnesses can also elevate lipase.

Digestive-enzyme output

• Elevated serum lipase does not establish pancreatic exocrine insufficiency (EPI) or inadequate digestive-enzyme output. Blood lipase does not directly measure enzyme secretion into the gut or effective digestion.
• With advanced chronic pancreatic damage, reported associations tend toward lower, rather than higher, serum lipase; even low values are not diagnostic of EPI.
• The appropriate initial test is fecal elastase-1 on a semi-solid or solid stool sample: <100 μg/g supports EPI, while 100–200 μg/g is indeterminate. At <200 μg/g, pooled sensitivity was 94% and specificity 69%.

Bottom line

• An elevated lipase can signal pancreatic injury or impaired renal clearance, but it should not be used to infer inadequate digestive-enzyme output; suspected EPI requires fecal elastase-1 and clinical correlation.